戻る Agenda
S14 : Can RWD Address Patient Enrollment Challenges? – Toward a Future Where Effective RWD Use Is Standard in Drug Development
Session Chair(s)
Jun Sakurai
Assistant Professor, Center for Innovative Clinical Medicne
Okayama University Hospital, Japan
Speaker(s)
Tomoyuki Takase
Eli Lilly Japan K.K., Japan
Kanako Katsuyama
Ministry of Health, Labor and Welfare, Japan
Assistant Director, Pharmaceutical Safety Division, Pharmaceutica
Takenori Ogawa
Medical Data Vision Co., Ltd., Japan
General Manager, Clinical Trial Division, EBM Division
Daisuke Nosaka, MD, PhD
Chugai Pharmaceutical Co., Ltd., Japan
Medical Science Department, Medial Affairs Division